Health TrialsbyHealthPanel

Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

ConditionsOsteoarthritisTendinitisSports InjuryDegenerative Disc DiseaseDegenerative ArthritisLigament InjuryNeuropathyPelvic Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorR3 Stem Cell

About this trial

The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 18 and over.

Ability to attend follow up visits or at least converse on phone or complete email follow up forms.

Disqualifiers

Active Infection

Pregnancy, Lactating

Clotting disorder

Trial design

Design model

Single group

Treatments tested in this trial

  • Umbilical Allograft

    Other intervention

    The umbilical allograft is regulated by the FDA and comes from a lab that is FDA registered.

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Umbilical AllograftExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Short Musculoskeletal Function Assessment Questionnaire (SMFA)

The Short Musculoskeletal Function Assessment Questionnaire (SMFA) is designed to measure the functional status of patients with a broad range of musculoskeletal injuries and disorders.

Time frame
Baseline and then Assess Changes Post Intervention at 4 weeks, 3 mths, 6 mths, 9 mths and one year

Secondary outcomes

1

Work Status

Not Working, Part Time, Full Time, Retired

Time frame
Baseline and then Assess Changes Post Intervention at 4 weeks, 3 mths, 6 mths, 9 mths and one year
2

Visual Analog Scale (VAS)

Assesses pain based on a scale from 0 to 100

Time frame
Baseline and then Assess Changes Post Intervention at 4 weeks, 3 mths, 6 mths, 9 mths and one year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

R3 Stem Cell

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: